Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 11.


Petraitis, Vidmantas, Petraitiene, Ruta, McCarthy, Matthew W, Kovanda, Laura L ORCID: 0000-0002-4493-4652, Zaw, Myo H, Hussain, Kaiser, Shaikh, Naima, Maung, Bo Bo W, Sekhon, Navjot K, Hope, William W ORCID: 0000-0001-6187-878X
et al (show 1 more authors) (2017) Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (9).


Kovanda, Laura L, Walsh, Thomas J, Jr, Benjamin Daniel K, Arrieta, Antonio, Kaufman, David A, Smith, P Brian, Manzoni, Paolo, Desai, Amit V, Kaibara, Atsunori, Bonate, Peter L
et al (show 1 more authors) (2018) Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 37 (6). 580 - 585.


Desai, Amit V, Kovanda, Laura L ORCID: 0000-0002-4493-4652, Hope, William W ORCID: 0000-0001-6187-878X, Andes, David, Mouton, Johan W, Kowalski, Donna L, Townsend, Robert W, Mujais, Salim and Bonate, Peter L
(2017) Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (12).


Kovanda, Laura L ORCID: 0000-0002-4493-4652, Marty, Francisco M, Maertens, Johan, Desai, Amit V, Lademacher, Christopher, Engelhardt, Marc, Lu, Qiaoyang and Hope, William W ORCID: 0000-0001-6187-878X
(2017) Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (6).


Kovanda, Laura L ORCID: 0000-0002-4493-4652, Desai, Amit V, Lu, Qiaoyang, Townsend, Robert W, Akhtar, Shahzad, Bonate, Peter and Hope, William W ORCID: 0000-0001-6187-878X
(2016) Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 60 (8). 4568 - 4576.


Andes, David R, Ghannoum, Mahmoud A, Mukherjee, Pranab K, Kovanda, Laura L ORCID: 0000-0002-4493-4652, Lu, Qiaoyang, Jones, Mark E, Henriksen, Anne Santerre, Lademacher, Christopher and Hope, William W ORCID: 0000-0001-6187-878X
(2019) Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (1).


Kovanda, Laura L ORCID: 0000-0002-4493-4652, Giamberardino, Charles, McEntee, Laura, Toffaletti, Dena L, Franke, Kelly S, Bartuska, Andrew, Smilnak, Gordon, de Castro, George C, Ripple, Katelyn, Hope, William W ORCID: 0000-0001-6187-878X
et al (show 1 more authors) (2019) Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (9).


Kovanda, Laura L ORCID: 0000-0002-4493-4652, Petraitiene, Ruta, Petraitis, Vidmantas, Walsh, Thomas J, Desai, Amit, Bonate, Peter and Hope, William W ORCID: 0000-0001-6187-878X
(2016) Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71 (7). 1885 - 1891.


Jr, Benjamin Daniel K, Kaufman, David A, Hope, William W ORCID: 0000-0001-6187-878X, Smith, P Brian, Arrieta, Antonio, Manzoni, Paolo, Kovanda, Laura L, Lademacher, Christopher, Isaacson, Brigit, Jednachowski, Deborah
et al (show 3 more authors) (2018) A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 37 (10). 992 - 998.


Kovanda, Laura L ORCID: 0000-0002-4493-4652, Sullivan, Sean M, Smith, Larry R, Desai, Amit V, Bonate, Pete L and Hope, William W ORCID: 0000-0001-6187-878X
(2019) Population Pharmacokinetic Modeling of VL-2397, A Novel Systemic Antifungal Agent: Analysis of a Single and Multiple Ascending Dose Study in Healthy Subjects. Antimicrobial agents and chemotherapy.


Kovanda, Laura L ORCID: 0000-0002-4493-4652, Desai, Amit V and Hope, William W ORCID: 0000-0001-6187-878X
(2017) Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 44 (2). 143 - 151.

This list was generated on Sun Nov 29 09:11:56 2020 GMT.